Multivalent HIV Vaccine Induces Early and Potent Antibody Response

A multivalent HIV vaccine which is composed of envelope protein (gp120 Env) and DNA or NYVAC vectors during priming leads to early and potent IgG-binding antibody answers, based on results in the HIV Vaccine Trials Network (HVTN). Reuters Health Information

Related posts

Leave a Comment